Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kenneth J Pienta

Showing results (241-250 of 519) with videos related to

Pageof 52
Sort By:
PET Clinics|October 13, 2022
<sup>18</sup>F-Labeled Radiotracers for Prostate-specific Membrane Antigen: Historical Perspective and Future DirectionsSteven P Rowe, Ali Salavati, Rudolf A Werner, et al.
Seminars in Nuclear Medicine|June 23, 2019
Prostate-Specific Membrane Antigen (PSMA)-Targeted PET Imaging of Prostate Cancer: An Update on Important PitfallsSara Sheikhbahaei, Rudolf A Werner, Lilja B Solnes, et al.
Neoplasia (New York, N.Y.)|August 8, 2022
Targeting interleukin 4 receptor alpha on tumor-associated macrophages reduces the pro-tumor macrophage phenotypeAmber E de Groot, Kayla V Myers, Timothy E G Krueger, et al.
Medical Oncology (Northwood, London, England)|August 29, 2023
Targeting MerTK decreases efferocytosis and increases anti-tumor immune infiltrate in prostate cancerKayla V Myers Chen, Amber E de Groot, Sabrina A Mendez, et al.
Neoplasia (New York, N.Y.)|July 17, 2004
Detection and isolation of circulating tumor cells in urologic cancers: a reviewRobert D Loberg, Yaron Fridman, Brian A Pienta, et al.
Clinical Nuclear Medicine|August 15, 2017
An Unusual Case of Penile Prostate Cancer Uncovered by Multiparametric MRI and PSMA-Targeted 18F-DCFPyL PET/CTSteven P Rowe, Michael A Gorin, Linda C Chu, et al.
Urology Case Reports|December 12, 2017
Complete biochemical response after stereotactic ablative radiotherapy of an isolated prostate cancer pelvic soft tissue recurrence detected by 18F-DCFPyL PET/CTRyan M Phillips, Michael A Gorin, Steven P Rowe, et al.
Convergent Science Physical Oncology|March 13, 2018
Epithelial and mesenchymal prostate cancer cell population dynamics on a complex drug landscapeKe-Chih Lin, Gonzalo Torga, Amy Wu, et al.
Journal of Cellular Biochemistry|August 28, 2014
The presence of androgen receptor elements regulates ZEB1 expression in the absence of androgen receptorSteven M Mooney, Princy Parsana, James R Hernandez, et al.
Neoplasia (New York, N.Y.)|August 23, 2002
Suppression of tumor recurrence and metastasis by a combination of the PHSCN sequence and the antiangiogenic compound tetrathiomolybdate in prostate carcinomaKenneth L van Golen, LiWei Bao, George J Brewer, et al.
Pageof 52

Showing results (241-250 of 519) with videos related to

Sort By:
Pageof 52
PET Clinics|October 13, 2022
<sup>18</sup>F-Labeled Radiotracers for Prostate-specific Membrane Antigen: Historical Perspective and Future DirectionsSteven P Rowe, Ali Salavati, Rudolf A Werner, et al.
Seminars in Nuclear Medicine|June 23, 2019
Prostate-Specific Membrane Antigen (PSMA)-Targeted PET Imaging of Prostate Cancer: An Update on Important PitfallsSara Sheikhbahaei, Rudolf A Werner, Lilja B Solnes, et al.
Neoplasia (New York, N.Y.)|August 8, 2022
Targeting interleukin 4 receptor alpha on tumor-associated macrophages reduces the pro-tumor macrophage phenotypeAmber E de Groot, Kayla V Myers, Timothy E G Krueger, et al.
Medical Oncology (Northwood, London, England)|August 29, 2023
Targeting MerTK decreases efferocytosis and increases anti-tumor immune infiltrate in prostate cancerKayla V Myers Chen, Amber E de Groot, Sabrina A Mendez, et al.
Neoplasia (New York, N.Y.)|July 17, 2004
Detection and isolation of circulating tumor cells in urologic cancers: a reviewRobert D Loberg, Yaron Fridman, Brian A Pienta, et al.
Clinical Nuclear Medicine|August 15, 2017
An Unusual Case of Penile Prostate Cancer Uncovered by Multiparametric MRI and PSMA-Targeted 18F-DCFPyL PET/CTSteven P Rowe, Michael A Gorin, Linda C Chu, et al.
Urology Case Reports|December 12, 2017
Complete biochemical response after stereotactic ablative radiotherapy of an isolated prostate cancer pelvic soft tissue recurrence detected by 18F-DCFPyL PET/CTRyan M Phillips, Michael A Gorin, Steven P Rowe, et al.
Convergent Science Physical Oncology|March 13, 2018
Epithelial and mesenchymal prostate cancer cell population dynamics on a complex drug landscapeKe-Chih Lin, Gonzalo Torga, Amy Wu, et al.
Journal of Cellular Biochemistry|August 28, 2014
The presence of androgen receptor elements regulates ZEB1 expression in the absence of androgen receptorSteven M Mooney, Princy Parsana, James R Hernandez, et al.
Neoplasia (New York, N.Y.)|August 23, 2002
Suppression of tumor recurrence and metastasis by a combination of the PHSCN sequence and the antiangiogenic compound tetrathiomolybdate in prostate carcinomaKenneth L van Golen, LiWei Bao, George J Brewer, et al.
Pageof 52